Internal Medicine, Rheumatology · Haddon Township, NJ
NPI
1346400207
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
216 Haddon Ave, Ste 100
Haddon Township, NJ, 08108
Phone (856) 429-7512
Groups this clinician bills Medicare through
Medicare paid, 2024
$902K
105,809 services
Medicare patients, 2024
488
Average age 70
Drug cost, 2024
$2.0M
3,498 prescriptions
Company payments, 2025
$1,108
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richa Mishra was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 65,600 times for 27 patients. In total Richa Mishra billed 105,809 services in 25 codes, and Medicare paid $902K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 65,600 | 27 | $3.62 | $238K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 16,320 | 87 | $0.10 | $1,579 |
| J0897 Injection, denosumab, 1 mg | Office | 7,260 | 86 | $19.71 | $143K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,600 | 14 | $32.69 | $216K |
| J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 1,425 | 15 | $4.24 | $6,040 |
| 99215 Office E&M - Established | Office | 672 | 268 | $144.37 | $97K |
| 99214 Office E&M - Established | Office | 594 | 315 | $79.46 | $47K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 581 | 293 | $13.35 | $7,758 |
| 96401 Chemotherapy Administration | Office | 491 | 124 | $59.24 | $29K |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 208 | 56 | $4.43 | $922 |
| 96413 Chemotherapy Administration | Office | 179 | 36 | $101.42 | $18K |
| 20611 Joint Injection | Office | 160 | 83 | $88.99 | $14K |
| 99204 Office E&M - New | Office | 106 | 106 | $123.47 | $13K |
| 20610 Joint Injection | Office | 87 | 47 | $65.66 | $5,712 |
By year: 2022 $1.3M for 116,273 services; 2023 $883K for 76,422 services; 2024 $902K for 105,809 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richa Mishra prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 440 prescriptions and refills. In total Richa Mishra wrote 3,498 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 440 | 1,073 | 141 | $26K |
| Prednisone Generic | 368 | 597 | 149 | $2,278 |
| Meloxicam Generic | 360 | 653 | 141 | $1,647 |
| Methotrexate Methotrexate Sodium | 287 | 684 | 101 | $9,445 |
| Gabapentin Generic | 235 | 521 | 90 | $3,427 |
| Celecoxib Generic | 150 | 300 | 58 | $6,658 |
| Benlysta Belimumab | 118 | 118 | 14 | $420K |
| Methylprednisolone Generic | 116 | 126 | 70 | $722 |
| Duloxetine Hcl Generic | 116 | 236 | 46 | $2,158 |
| Alendronate Sodium Generic | 80 | 196 | 27 | $904 |
| Diclofenac Sodium Generic | 74 | 138 | 35 | $1,198 |
| Cyclobenzaprine Hcl Generic | 64 | 116 | 29 | $798 |
| Cevimeline Hcl Generic | 62 | 122 | 29 | $16K |
| Allopurinol Generic | 58 | 135 | 15 | $577 |
| Azathioprine Generic | 53 | 97 | 18 | $2,426 |
Brand drugs: - claims; generic drugs: 3,043 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richa Mishra $1,108 ($1,108 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $564.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.